Commercial advisory services to inform the evaluation process involved in decisions about potentially in-licensing or purchasing a biotech, pharmaceutical, diagnostic or device asset or potentially investing in a company with this type of asset by providing primary market research to quantify expected physician demand and inform a data-driven revenue model for that asset